New Study Results: Calmare Pain Device Therapy May Reduce Chemotherapy-Induced Pain Scores by About 30%
The results of a recently published, single-arm clinical study in the Journal of Pain and Palliative Care Pharmacotherapy, (December 2013) demonstrated how a cohort of 39 chronic, chemotherapy- induced peripheral neuropathy (CIPN) patients experienced an average pain score reduction of 31.8% in their level of chronic pain undergoing Calmare® Pain Device therapy – Competitive Technologies, Inc., (CTI) flagship medical product.
View full press release